Department of Anesthesiology and Reanimation, Gülhane Military Medical Academy, Ankara, Turkey.
J ECT. 2013 Mar;29(1):37-40. doi: 10.1097/YCT.0b013e318271200b.
To compare propofol and sodium thiopental as anesthetic agents for electroconvulsive therapy (ECT) in major depression with respect to clinical effect.
Participants were composed of 96 patients with depression who were administered either propofol or sodium thiopental as an anesthetic agent for bilateral ECT. The Hamilton Depression Rating Scale was administered at baseline and after 6 treatments. Algorithm-based charge dosing was used.
There was a statistically significant difference between the groups regarding postintervention Hamilton Depression Rating Scale score. The preintervention mean (SD) scores in the propofol group and the sodium thiopental group were 37.3 (2.2) and 36.7 (1.2), respectively. The postintervention mean (SD) scores in the propofol group and the sodium thiopental group were 10.7 (1.8) and 13.4 (3.3), respectively. No correlation was found between clinical response and age, weight, and body mass index. There was no association between the groups' seizure time and duration of recovery.
In conclusion, propofol may improve major depressive disorder more than sodium thiopental in patients who are receiving ECT.
比较丙泊酚和硫喷妥钠作为麻醉剂在治疗重度抑郁症患者的电抽搐治疗(ECT)中的临床效果。
将 96 例接受丙泊酚或硫喷妥钠作为双侧 ECT 麻醉剂的抑郁症患者作为研究对象。在基线和 6 次治疗后使用汉密尔顿抑郁量表进行评估。采用基于算法的收费剂量。
两组之间干预后汉密尔顿抑郁量表评分存在统计学差异。丙泊酚组和硫喷妥钠组干预前的平均(SD)评分分别为 37.3(2.2)和 36.7(1.2),干预后的平均(SD)评分分别为 10.7(1.8)和 13.4(3.3)。临床反应与年龄、体重和体重指数之间无相关性。两组的癫痫发作时间和恢复时间之间没有关联。
总之,在接受 ECT 的患者中,丙泊酚可能比硫喷妥钠更能改善重度抑郁症。